Responsive image

Common name


3-amino-4-methyl-N-phenyl-benzamide

IUPAC name


3-amino-4-methyl-N-phenyl-benzamide

SMILES


c1cc(ccc1)NC(=O)c2cc(c(cc2)C)N

Common name


3-amino-4-methyl-N-phenyl-benzamide

IUPAC name


3-amino-4-methyl-N-phenyl-benzamide

SMILES


c1cc(ccc1)NC(=O)c2cc(c(cc2)C)N

INCHI


InChI=1S/C14H14N2O/c1-10-7-8-11(9-13(10)15)14(17)16-12-5-3-2-4-6-12/h2-9H,15H2,1H3,(H,16,17)

FORMULA


C14H14N2O

Responsive image

Common name


3-amino-4-methyl-N-phenyl-benzamide

IUPAC name


3-amino-4-methyl-N-phenyl-benzamide





Molecular weight


226.274

clogP


2.362

clogS


-3.740

Frequency


0.0003





HBond Acceptor


1

HBond Donor


3

Total Polar
Surface Area


55.12

Number of Rings


2

Rotatable Bond


2

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD01336 Nilotinib Responsive image Antineoplastic Agents; Immunosuppressive Agents; Protein Kinase Inhibitors; Antineoplastic and Immunomodulating Agents; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; For the potential treatment of various leukemias, including chronic myeloid leukemia (CML).
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
3gp0_ligand_3_2.mol2 3gp0 1 -8.75 O=C(Nc1ccccc1)c1ccc(c(c1)N)C 17
2oo8_ligand_3_110.mol2 2oo8 1 -8.68 c1cc(ccc1)NC(=O)c1cc(c(cc1)C)N 17
3be2_ligand_3_110.mol2 3be2 1 -8.47 Nc1cc(C(=O)Nc2ccccc2)ccc1C 17
2oo8_ligand_4_185.mol2 2oo8 0.949153 -8.91 Nc1cc(C(=O)Nc2cc(ccc2)C)ccc1C 18
3be2_ligand_4_185.mol2 3be2 0.949153 -8.69 Nc1cc(C(=O)Nc2cc(C)ccc2)ccc1C 18
4x7j_ligand_2_9.mol2 4x7j 0.883333 -8.58 c1(ccccc1)NC(=O)c1c(cc(cc1)C)N 17
2hz0_ligand_2_0.mol2 2hz0 0.839286 -8.73 C(=O)(Nc1ccccc1)c1ccccc1 15
5ew3_ligand_2_4.mol2 5ew3 0.839286 -8.57 c1cccc(c1)C(=O)Nc1ccccc1 15
103 , 11